1990
Dr. John Kulig, MPH, is director of Adolescent Medicine at Tufts-New England Medical Center (T-NEMC) and a professor of pediatrics, public health, and family medicine at the Tufts University School of Medicine. He was recently elected to a two-year term as subspecialty chair of the Adolescent Medicine Subboard of the American Board of Pediatrics. Kulig developed the adolescent medicine program at T-NEMC and founded the Student Health Center at Boston High School, one of the city's first school-based clinics. He also serves as the volunteer medical director for the Chernobyl Children Project USA.
Dr. John Rich, MPH, was a 2006 recipient of a MacArthur Fellowship for his work in addressing the primary health care needs of young urban men, including the establishment of the Young Men’s Health Clinic, an offshoot of Boston Medical Center, in 1993. Rich recently left his position as medical director of the Boston Public Health Commission to join Drexel University’s School of Public Health as chair of the Department of Health Management and Policy. He is also working on a violence prevention program in collaboration with Temple University, University of Pennsylvania, and Children’s Hospital in Philadelphia.
1991
Mark Benjamin, SD, is the new president and chief executive officer of Galenea Corporation, a privately held biopharmaceutical company focused on discovering and developing drugs to treat schizophrenia and other central nervous system disorders. Prior to joining the company, he was chief business officer of Nura Inc., a neuroscience drug discovery company. His experience in the pharmaceutical and biotech industries also includes positions as vice president of global business development for Manteia SA and senior business development executive at Rosetta Inpharmatics.
Dr. Jay M. Burstein, MPH, of Southborough, MA, has been named Medical Director of Corporate Core, the Occupational Health and Safety Service of St. Joseph Hospital for Specialty Core. He will be responsible for patient care, clinical care protocols, oversight of performance improvement standards as well as outreach and consultation with clients and area businesses. Dr. Burstein is a certified medical review officer and a diplomate of the National Board of Medical Examiners.
Dr. Kevin Vigilante, MPH, is a clinical associate professor of medicine at the Brown University School of Medicine. Vigilante recently completed a sabbatical with Booz Allen Hamilton, a global strategy and technology consulting firm specializing in health care management, providing services to the Veterans Affairs' Capital Asset Realignment for Enhanced Services (CARES) project and Metro TeenAIDS. At the Miriam Hospital in Providence, RI, Vigilante implemented a care network for at-risk inner-city populations, a program integral to a strategy described by the Journal of the American Medical Association as a "national model for correctional care."
1992
Lynn Berner, MPH, has recently joined the Sisters of Charity Foundation of Cleveland as program officer for partnerships and learning. The foundation seeks to encourage systemic changes that build healthy families and communities by tackling the root causes of poverty. Berner brings to her new position 10 years in health care law and policy. Her prior work experience includes serving as a consultant to the Ohio Commission to Reform Medicaid and as a staff attorney for the Cleveland Clinic, where she focused on health care legislation, regulation, and quality of care.
Dr. Linda Clayton, MPH, received an honorary doctorate from North Carolina Central University, May 2005.
1993
Gail C. Chun-Gannon, SM, recently joined the JHD Group, a health-care management partnering firm that advises large physician and hospital organizations on how to improve operational and financial results while enhancing the quality of care and services. Gannon brings 15 years of health-care consulting experience to her position, where she intends to develop innovative health information exchange models through private-public partnerships. Prior to joining JHDG, Gannon was the principal of Ensanté Consulting, working with health-care delivery services, and developing health policy impact assessments for government agencies.
1994
Dr. Michael C. Caldwell, MPH, has been reappointed as the Dutchess County Commissioner of Health in New York for his third consecutive six-year term. Caldwell oversees the health of nearly 300,000 people in the county. He has served as commissioner since 1994, and was one of the youngest physicians ever to be appointed a health commissioner in the United States. He was also the youngest president of the National Association of County & City Health Officials (NACCHO).
Dr. Diana Rodriguez, MPH joined the medical staff at Caritas St. Elizabeth's Medical Center in Boston. “I anticipate a very full practice at Caritas St. Elizabeth’s, where I’ll also be able to pursue my special interests in critical care obstetrics, prenatal diagnosis, HIV in pregnancy and chronic hypertension in women,” said Dr. Rodriguez.
1995
Dr. Mark Kortepeter, MPH '95, recently published "Biohazard 9-1-1," a thriller about a small town doctor in the Adirondacks who finds himself fighting a horrific disease with global implications. Dr. Kortepeter is an infectious disease and public health physican in Washington, D. C., with expertise in biodefense and hazardous infectious diseases.
Dr. Johan Thor, MPH '95, received the Karolinska Medical Management Centre/European Health Management Association Research Award for his article titled "Learning Helpers: How they Facilitated Improvement and Improved Facilitation. Lessons form a Hospital-wide Quality Improvement Initiative."
Dr. Bart Harmon, MPH, chief medical officer of Harris Corporation's Healthcare Solutions business, has been named to the American Health Information Community (AHIC) Successor Transition Planning Group. Dr. Harmon is one of 11 distinguished public-private sector healthcare industry leaders in the U.S. to be named to the group. The AHIC is a federal advisory board established in 2005 to make recommendations about how to accelerate the nationwide adoption of interoperable healthcare information technology.
1996
Christine Huttin, TF, was featured in the Journal of Biolaw and Business, Vol. 8, No. 4, 2005. Her article, "Pharmacogenomic Technologies and the Health Industry Model" discusses the various ways pharmacogenomics technologies can modify speed and diffusion of innovation and factor demands in economies and health care systems according to different types of models of care, especially when they reach applicability in clinical practice.
Christine Huttin is a Research Professor and Founder of the Virtual Development Center INDEPUS research. She is also a visiting Professor at University of California (Berkeley) and Research Director for ENDEP Europe. She received her BA, MBA, and PhD in Business and Political economy from EHESS/ESSEC (Paris, France). She also was a Takemi Fellow in International Health at Harvard School of Public Health, and was trained in epidemiology by the New England Epidemiology Institute. She gained worldwide recognition in North America, Europe and Asia for her expertise and scientific contributions on pharmaceutical economics and policies.
Dr. Maura Daly Iversen, SD, assistant professor in the Department of Medicine at Brigham and Women's Hospital and Harvard Medical School, and professor and associate director of graduate programs in physical therapy at the Massachusetts General Hospital Institute of Health Professions, has been named the recipient of the 2007 Lawrence H. Daltroy Fellowship in Provider-Patient Communication from the American College of Rheumatology. Iversen will use her fellowship support to create and evaluate high- and low-fidelity medical simulations used in medical training, and to coordinate interdisciplinary team care, particularly in rheumatology. Iversen also serves on the medical and research curriculum committees for the United States Bone and Joint Decade, a global campaign to improve the lives of those with musculoskeletal conditions.
Dr. Brian Murphy, MPH, has been appointed chief medical officer of Epiphany Biosciences, Inc., a San Francisco-based company that focuses on advancing new therapies for infectious disease. Murphy has more than 15 years of experience in developing antiviral therapeutics for use around the globe. Prior to joining Epiphany, Murphy worked at Valeant Pharmaceuticals International as chief medical officer and vice president of Global Medical Affairs.
Dr. William Bruce Owusu, SD, a senior lecturer in the Department of Nutrition and Food Science at the University of Ghana, is a recipient of the Joint-Best Researcher Award for Science for his contributions to the field of child nutrition. He has coordinated the Child Health and Development Project with the university's school of public health and served as co-investigator to the World Health Organization's Multicentre Growth Reference Study. In addition to reviewing and updating the nutrition syllabi for nursing and public health institutions as a key member of the national Pre-service Nutrition Curricula Development, Owusu is working to improve micronutrition for Ghana's National Food Fortification Alliance.
1997
Donna Fox, SM, is vice president of government affairs at Cambridge Health Alliance, in Massachusetts (CHA), a 350-bed, three-hospital system with more than 20 primary care practices. Through her legislative advocacy and public testimony before the legislature and regulatory agencies, Fox works on shaping policies for Medicaid, Medicare, the state's Uncompensated Care Pool, and other public health programs. Since assuming her position in 2003, she has implemented CHA's first government-relations program and developed a Medicaid health plan. Fox was one of 12 U.S. health care executives to win a 2005 "Up & Comer" award from Modern Healthcare magazine.
Dr. Onyekachi Ifudu, SM, is the editor of Inner-City Nephrology, published by ArtHouse in 2004. Mr. Ifudu is an associate professor of medicine at SUNY Downstate Medical Center in Brooklyn, New York.
Howard H. Moffet, MPH, is conducting health services research at Kaiser Permanente Northern California Division of Research in Oakland, CA. He has recently published a paper "Ethnic Disparities in Diabetic Complications in an Insured Populations" in the Journal of the American Medical Association. Last year, he was appointed by Governor Gray Davis to the California Acupuncture Board.
Dr. Ranna Parekh, MPH, is a full-time practicing psychiatrist for children and adults at Massachusetts General Hospital in Boston, with a speciality in substance abuse disorders among adolescents. With adults, she concentrates primarily on conflict-resolution. Since 2002 she has worked with Watershed Associates, a Washington, D.C.-based negotiations consulting firm, helping companies such as NASA, Chevron, and Merck resolve conflict and negotiate successfully, particularly in emotionally-charged situations.
Dr. Saleh Rahman, MPH, received the Early Career Award from the American Public Health Association during the 2006 Public Health Education and Health Promotion awards luncheon. Rahman is an assistant professor of behavioral science and health education at the Institute of Public Health at Florida A & M University. His career path has spanned two continents: along with his work in the United States, he has practiced medicine in Bangladesh, where he was born, and has collaborated with the World Health Organization on diabetes prevention. His research interests also include health disparities, human rights, hunger alleviation, cancer, and HIV/AIDS.
Suresh Babu Rangarajan, SM, a graduate of the University of Michigan Medical School, is volunteering in Bolivia for one year prior to beginning a residency in Medicine and Pediatrics in the United States, starting June 2005. He has been helping children with serious burn wounds in Bolivian hospitals by sending them to the Shriners Hospital in Cincinnati for expert pediatric burn treatment.
Osula Evadne Rushing, SM, is a senior program associate at Grantmakers in Health, which provides training, technical assistance, and networking opportunities to the staffs and trustees of foundations and corporate giving programs. Rushing develops programs and publications to help these philanthropic organizations improve access to health care. Previously she worked at the Henry J. Kaiser Family Foundation as a policy analyst, focusing on race, ethnicity, and health care; the Boston Foundation, where she helped develop a project to measure community changes at the neighborhood, city, and regional levels; and at the Education Development Center, where she coordinated a national hate crime prevention and response project funded by the U.S. Departments of Justice and Education.
1998
Veenu Aulakh, SM, is the senior program officer for the Chronic Disease Care Program at the California HealthCare Foundation. Previously, Ms. Aulakh was a consultant in the Care Management Institute and was a senior project manager in the regional health education department at Kaiser Permanente.
Rebecca James Baker, MPH, died on August 8, 2004, at her home in Durham, North Carolina.
Dr. Alan Colowick, MPH, has been appointed president of the Oncology Division at Geron Corporation, a California-based biotechnology company that develops therapeutic products for the treatment of cancer and degenerative diseases. In this role he will oversee operational and strategic activities for oncology product development. Colowick worked for Amgen Inc., as vice president of European Medical Affairs, where he managed product development in hematology, oncology, nephrology, and internal medicine, among other areas.
Dr. Edward B. Feinberg, MPH, was appointed professor and chair of the Department of Ophthalmology at Boston University School of Medicine, which he joined in 1999, and was named chief of ophthalmology at Boston Medical Center.
1999
Dr. Linda Marc, SM, SM ’04, SD ’05, was recently selected to serve on the U.S. Census Bureau’s Advisory Committee on the African-American population by Secretary of Commerce Carlos Gutierrez. As a member of the nine-person committee, she will advise the bureau on ways to achieve a more accurate count of African-Americans in the 2010 census. Marc is a lecturer in public health practice at the Yale School of Public Health and conducts research in HIV/AIDS and minority health issues.
John Paul SanGiovanni, SD, works as a staff scientist in the Clinical Trails Branch of National Eye Institute of the National Institutes of Health. He also serves as Project Officer of two 4000-person clinical trials examining the relationship of nutrients with age-related macular degeneration (AMD). In this capacity he has planned and serves as co-PI a number projects that have elucidated possible preventive interventions and treatments for blinding retinal diseases of public heath significance (published in Nature Medicine, 7 July 2007). He was part of one of the first teams to successfully apply of microarray technology for identifying susceptibility loci in a common a complex disease (published in Science, 2005). He is currently directing projects at the NIH examining: (1) the molecular genetics of AMD; and (2) the measurement properties of a non-intrusive in vivo imaging system designed to measure retinal metabolism in humans.